Cargando…

Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes

BACKGROUND: A chronic disease impacts a patient’s daily life, with the burden of symptoms and managing the condition, and concerns of progression and disease complications. Such aspects are captured by Patient-Reported Outcomes Measures (PROM), assessments of e.g. wellbeing. Patient-Reported Experie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borg, Sixten, Gerdtham, Ulf-G., Eeg-Olofsson, Katarina, Palaszewski, Bo, Gudbjörnsdottir, Soffia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836539/ https://www.ncbi.nlm.nih.gov/pubmed/31696324 http://dx.doi.org/10.1186/s13561-019-0248-4

Ejemplares similares

Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden
por: Borg, Sixten, et al.
Publicado: (2019)

Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden
por: Borg, Sixten, et al.
Publicado: (2014)

Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes – a nationwide cross-sectional study
por: Svedbo Engström, Maria, et al.
Publicado: (2019)

New Diabetes Questionnaire to add patients’ perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables
por: Svedbo Engström, Maria, et al.
Publicado: (2020)

Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes: A report from the Swedish National Diabetes Register
por: Eliasson, Björn, et al.
Publicado: (2011)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

HbA1C and Cancer Risk in Patients with Type 2 Diabetes – A Nationwide Population-Based Prospective Cohort Study in Sweden
por: Miao Jonasson, Junmei, et al.
Publicado: (2012)

Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes: An observational study from the Swedish National Diabetes Register (NDR)
por: Eeg-Olofsson, Katarina, et al.
Publicado: (2010)

Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Clinical Use and Effectiveness of Lipid Lowering Therapies in Diabetes Mellitus—An Observational Study from the Swedish National Diabetes Register
por: Eliasson, Björn, et al.
Publicado: (2011)

Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study
por: Lugner, Moa, et al.
Publicado: (2021)

Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
por: Kiadaliri, Aliasghar A., et al.
Publicado: (2014)

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
por: Ekström, Nils, et al.
Publicado: (2012)

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study
por: Karlsson, Sofia Axia, et al.
Publicado: (2018)

Refill adherence and persistence to lipid‐lowering medicines in patients with type 2 diabetes: A nation‐wide register‐based study
por: Karlsson, Sofia Axia, et al.
Publicado: (2017)

Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register
por: Hero, Christel, et al.
Publicado: (2020)

Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
por: Hero, Christel, et al.
Publicado: (2021)

Weight Constrained DEA Measurement of the Quality of Life in Spanish Municipalities in 2011
por: González, Eduardo, et al.
Publicado: (2016)

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
por: Steineck, Isabelle, et al.
Publicado: (2015)

A DEA model for measuring financial intermediation
por: Boďa, Martin, et al.
Publicado: (2020)

Risk for developing perianal abscess in type 1 and type 2 diabetes and the impact of poor glycemic control
por: Adamo, Karin, et al.
Publicado: (2020)

Modeling performance measurement: applications and implementation issues in DEA
por: Cook, Wade D, et al.
Publicado: (2005)

What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored Patient-Reported Outcome Measure for the Swedish National Diabetes Register
por: Svedbo Engström, Maria, et al.
Publicado: (2016)

The significance of chronic kidney disease, heart failure and cardiovascular disease for mortality in type 1 diabetes: nationwide observational study
por: Eliasson, Björn, et al.
Publicado: (2022)

Excess Body Weight and Cancer Risk in Patients with Type 2 Diabetes Who Were Registered in Swedish National Diabetes Register – Register-Based Cohort Study in Sweden
por: Miao Jonasson, Junmei, et al.
Publicado: (2014)

Open carpal tunnel release and diabetes: a retrospective study using PROMs and national quality registries
por: Zimmerman, Malin, et al.
Publicado: (2019)

Survey of Blood Groups DEA 1, DEA 4, DEA 5, Dal, and Kai 1/Kai 2 in Different Canine Breeds From a Diagnostic Laboratory in Germany
por: Ebelt, Anne K., et al.
Publicado: (2020)

Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes
por: Höskuldsdóttir, Gudrun, et al.
Publicado: (2022)

Chemical Exposures: Will DEA Findings Wash?
por: Washam, Cynthia
Publicado: (2006)

Dr. Charles A. O’Dea
Publicado: (1918)

A Network-DEA model to evaluate the impact of quality and access on hospital performance
por: Afonso, G. P., et al.
Publicado: (2023)

Measuring Quality Gaps in TB Screening in South Africa Using Standardised Patient Analysis
por: Christian, Carmen S., et al.
Publicado: (2018)

Patients’ and Health Care Professionals’ Perceptions of the Potential of Using the Digital Diabetes Questionnaire to Prepare for Diabetes Care Meetings: Qualitative Focus Group Interview Study
por: Eeg-Olofsson, Katarina, et al.
Publicado: (2020)

Cohort Profile: The German Ageing Survey (DEAS)
por: Klaus, Daniela, et al.
Publicado: (2017)

Congestion in multi-function parallel network DEA
por: Kassaei, Sarvar Sadat, et al.
Publicado: (2023)

Patient Experiences after Open Trigger Finger Release in Patients with Type 1 and Type 2 Diabetes—A Retrospective Study Using Patient-reported Outcome Measures
por: Rydberg, Mattias, et al.
Publicado: (2023)

Ulnar Nerve Entrapment in Diabetes: Patient-reported Outcome after Surgery in National Quality Registries
por: Zimmerman, Malin, et al.
Publicado: (2020)

Measuring quality of life in rheumatic conditions
por: Walker, Janine G., et al.
Publicado: (2006)

Conference on New Uses of DEA in Management and Public Policy
por: Charnes, Abraham, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_tocqm01sbkst60k8c4bhmounmn